February 2004
Our Innovation Backlog
The flow of innovations is as strong as ever, but the U.S. is slipping in its ability to commercialize them.
By Kenan Sahin
Innovation and entrepreneurship have been a major part of my life. As a student at MIT, and later as a faculty member, I was constantly immersed in both. In 1982, I started a small software-systems development company with a $1,000 investment, entering an innovation and entrepreneurship vortex that carried me through the dot-com explosion. In 1999, Kenan Systems was purchased by Lucent Technologies, and I became an executive there, charged with advancing "Bell Labs innovation." After leaving Lucent two years later, I formed Tiax, which acquired the assets, contracts, and staff of Arthur D. Little's Technology and Innovation business, with its own legacy of helping commercialize innovations, from synthetic penicillin to advanced battery technologies.
![]() | Select from the choices above to read the entire article. |
Customer Service
|
Magazine Services
|
Subscribe
|
Other
|
Advertise
|


